An eventful quarter for Hemas; Q1 revenue up by 14.5%

1. HEMAS HOLDINGS PLC
Investor Presentation
Q1, 2013/14

2. Sri Lanka: Macro Highlights
7.9%
6.4%
4.8%
6.4%
6.0%
Q1 2012 Q2 2012 Q3 2012 Q4 2012 Q1 2013
Economic Growth
12.88% 13.02%
11.69%
11.35%
10.66% 10.56%
Q1 2012 Q2 2012 Q3 2012 Q4 2012 Q1 2013 Jul 2013
135.46 131.17 128.82 128.47 132.08 133.15
Jun 2012 Sept 2012 Dec 2012 Mar 2013 Jun 2013 Jul 2013
9.3% 9.1% 9.2%
7.5% 6.8% 6.1%
Jun 2012 Sept 2012 Dec 2012 Mar 2013 Jun 2013 Jul 2013
12M T-Bill rate
Exchange Rate
Inflation
Economic growth slows down to 6%
Interest rates drop to 10.56% in July
Rupee depreciates to Rs.133/USD in July
2013
YoY inflation drops to 6.1%; annual average
at 8.3%
Source: CBSL

3. HemasGroup: A Snapshot
Share Price (As at 19.08.2013) Rs. 33.00
Market Capitalization Rs. 17Bn
% ofTotal Market 0.70%
PER 15.4*
PBV 1.37
No of Shares 515Mn
Public Shareholding 28.33%
-
5.0
10.0
15.0
20.0
25.0
30.0
Mar 2012 June 2012 Sept 2012 Dec 2012 Mar 2013 Jun 2013
Sector & Market PER vs Hemas PER
Diversified Sector PER Market PER Hemas PER * PER is based on annualisedearnings

4. HemasGroup: Q1 Performance Highlights
Figures are in Rs. Mn Q1 2013/14 Q1 2012/13
Group Turnover 7,243 6,324 15%
Operating Profit 490 451 9%
Group Earnings 277 334 -17%
Cash from Operations 744 150 395%
% Change
Figures are in Rs. Mn Q1 2013/14 31st March 2013
Total Assets 29,472 26,008 13%
Shareholders’ Funds 12,374 12,153 2%
Capital Employed 21,678 19,339 12%
% Change
* Annualised
Q1 2013/14 Q1 2012/13
EPS* 2.15 2.60 -17%
Net Assets per Share 24.01 20.63 16%
ROE* 9.6% 13.5%
ROCE* 10.2% 11.4%
% Change

5. HemasGroup: Revenue
-10%
0%
10%
20%
30%
0
6,000
12,000
18,000
24,000
30,000
2008/09 2009/10 2010/11 2011/12 2012/13 2013/14
Rs.Mn Group Revenue
Revenue Growth
• Group revenue crossed Rs. 7Bn for the quarter, posting a growth of 14.5%YoY
• Revenue growth was mainly driven by the strong performance in
Healthcare, FMCG andTransportation sectors portraying a growth of 23%, 25%
and 57% respectively
• New Businesses J.L. Morison Son and Jones (Ceylon) PLC (JLM) and Panasian
Power PLC (PAP) contributed Rs. 215Mn and Rs. 65Mn to Group revenue since the
date of acquisition
15,342 14,997
18,067
21,533
26,098

6. HemasGroup: Operating Profit
• Operating Profit of the Group recorded a growth of 9% during Q1; mainly driven
by the impressive performance of Power and FMCG businesses
• New Businesses, JLM and PAP contributed Rs. 19Mn and Rs. 50Mn to Group
operating profit, post acquisition
• Group operating profit was negatively impacted by the closure of Hotel Dolphin
and Sigiriya for refurbishment and start up losses ofThalawathugoda Hospital
• Adjusted operating profit recorded an underlying growth of 38.9%
1,210
1,443
1,741 1,784
2,434
-25%
-10%
5%
20%
35%
50%
0
500
1,000
1,500
2,000
2,500
3,000
2008/09 2009/10 2010/11 2011/12 2012/13 2013/14
Rs.Mn Group Operating Profit
Op. Profit Growth

7. HemasGroup: Earnings
-40%
-20%
0%
20%
40%
60%
0
500
1,000
1,500
2,000
2008/09 2009/10 2010/11 2011/12 2012/13 2013/14
Rs.Mn Group Earnings
Earnings Growth
• Closure of the two key hotels and start up losses ofThalawathugoda Hospital
negatively impacted profit after tax; adjusted profit after tax recorded an
underlying growth of 19.1%
• Group earnings were reported at Rs. 277Mn posting a drop of 17.2% over last year
• Earnings drop resulted from increased finance costs on new investments
• Tax holiday enjoyed by our FMCG business expired in FY 2012/13; this year the
business pays tax at 10%, impacting Group earnings
775
902
1,210
1,165
1,658

8. Revenue and Earnings Contribution
Q1 Revenue Contribution Q1 Earnings Contribution
0%
20%
40%
60%
80%
100%
2010/11 Q1 2011/12Q1 2012/13 Q1 2013/14 Q1
FMCG Healthcae Leisure
Transportation Power Other -40%
-20%
0%
20%
40%
60%
80%
100%
2010/11 Q1 2011/12Q1 2012/13 Q1 2013/14 Q1
FMCG Healthcae Leisure
Transportation Power Other

9. FMCG: Performance Highlights
0
50
100
150
200
250
0
500
1,000
1,500
2,000
2,500
Q1 2009/10 Q1 2010/11 Q1 2011/12 Q1 2012/13 Q1 2013/14
Rs.MnRs.Mn Revenue and PAT
Revenue PAT
• Sector recorded a revenue of Rs. 2.2Bn and a profit after tax of Rs.221Mn for Q1 posting a
growth of 25% and 37% respectively
• Growth was mainly driven by the exceptional performance of Oral Care, PersonalWash
and Home Care categories
• Sector entered the fast growingAdult Skin Care market with the launch of “Cheramy
Touch”, a range of milk based skin care products with unique formulations
• “Pro Sport” launched two variants of Eau DeToilette Spray in the premium fragrance
space; an initiative was take to modernize the brand with the new expression ‘PRO’

10. Healthcare: Performance Highlights
• Healthcare sector posted a revenue of Rs.2.7Bn posting a growth of 23%, backed by the
growth in sales volumes of the Pharmaceutical business
• Hemas Pharmaceuticals secured its market leadership position with an improved market
share of 18.6% (Source:IMS) and was able to attract a new agency, Aristo Pharma, a leading
pharmaceutical company in Bangladesh
• Hospitals’ revenue grew by 22% with the steady pickup in volumes at Thalawathugoda
• Sector profitability dipped by 47% to record Rs. 72Mn on account of startup losses at our
new hospital
Rs.Mn Rs.Mn
0
40
80
120
160
0
500
1,000
1,500
2,000
2,500
3,000
Q1 2009/10Q1 2010/11Q1 2011/12Q1 2012/13Q1 2013/14
Revenue and PAT
Revenue PAT

11. Leisure: Performance Highlights
• Leisure sector posted a revenue of Rs. 209Mn, a drop of 28% resulting from the closure of
two key properties, Hotel Dolphin and Sigiriya for refurbishment
• Sector earnings recorded a loss of Rs. 81Mn in comparison to the profit of Rs. 15Mn
reported last year, stemming from the drop in revenue together with unrealized exchange
losses of Rs. 31Mn on foreign currency borrowings
• Profitability was further dampened by the recent electricity tariff hike and the increase in
staff costs due toWages Board directive effected from 1st April 2013
• The two key hotels are excepted to be opened in time for the upcoming winter season
Rs.Mn Rs.Mn
-120
-80
-40
0
40
0
100
200
300
400
Q1 2009/10 Q1 2010/11 Q1 2011/12 Q1 2012/13 Q1 2013/14
Revenue and PAT
Revenue PAT

12. Transportation: Performance Highlights
• Sector enjoyed a healthy quarter with revenue increasing by 57% to Rs. 357Mn
• The revenue growth was mainly driven by the addition of our new haulage and logistics
businesses
• The sector recorded profit after tax of Rs. 90Mn, a growth of 34%, mainly driven by the
aviation segment and addition of the haulage and logistics businesses
• The ground breaking ceremony of the new venture Hemas Integrated Logistics (Pvt)
Ltd., an integrated logistics facility for shippers and shipping lines took place during the
quarter, which includes a state-of-the-art container depot and a warehousing complex
0
20
40
60
80
100
0
100
200
300
400
Q1 2009/10 Q1 2010/11 Q1 2011/12 Q1 2012/13 Q1 2013/14
Revenue and PAT
Revenue PAT
Rs.MnRs.Mn

13. Power: Performance Highlights
• Power sector recorded a revenue of Rs. 1.4Bn; a drop of 5% due to the curtailment of
thermal power generation imposed by CEB
• The Hydro Power segment portrayed a notable growth in underlying revenue, to record
Rs. 106Mn from Rs. 37Mn posted last year, while PAP contributed Rs. 65Mn to sector
revenue, post acquisition
• Despite the drop in thermal power revenue, the sector posted a profit after tax of Rs.
137Mn, including a contribution of Rs. 50Mn from PAP, post acquisition
• The sector underlying profit growth, adjusted for new investment in PAP, was 170%
0
20
40
60
80
100
120
140
160
0
200
400
600
800
1,000
1,200
1,400
1,600
Q1 2009/10 Q1 2010/11 Q1 2011/12 Q1 2012/13 Q1 2013/14
Revenue and PAT
Revenue PAT
Rs.Mn Rs.Mn

14. J.L. Morison: Performance Highlights
• Consolidated revenue increased by 6% to Rs. 625Mn while earnings increased by 20% to
close at Rs. 30Mn
• Growth was driven largely by Pharmaceutical and Agro businesses
• Pharmaceutical & Diagnosis sector revenue grew by 15% during the quarter to report Rs.
301Mn, while Agro business grew by 81% to Rs. 82Mn
• Due to the impending loss of an agency, the Consumer sector experienced a 14% decline
to report a turnover of Rs. 242Mn
Consumer
39%
Pharma
48%
Agro
13%
Revenue Composition
0
5
10
15
20
25
30
35
40
0
100
200
300
400
500
600
700
Q1 2009/10 Q1 2010/11 Q1 2011/12 Q1 2012/13 Q1 2013/14
Revenue and PAT
Revenue PAT
Rs.Mn Rs.Mn
Post acquisition results ofJLM are consolidated into FMCG, Healthcare and Other segments

15. Corporate Social Responsibility
 Our 38th “Piyawara” preschool was opened in Keppapilavu model village in Mulativue
in June 2013 by President Mahainda Rajapaksa
 Hemas Pharmaceuticals provided an EmergencyTreatment Unit (ETU) worth of Rs.
4Mn to Aralaganwila Hospital, which was opened by Hon. Maithripala
Sirisena, Minister of Health
From a canvas tent to a proper preschool
 Aralaganwila, a rural farming village in
Polonnaruwa District, was in essential need of
an ETU at the Divisional hospital to provide
prompt life saving attention to patients facing
emergency injuries and accidents

16. Telephone: +94 11 4 731 731
Email: ir@hemas.com
Web: http://www.hemas.com
Hemas Holdings PLC
Hemas House, 75, Braybrooke Place, Colombo 2, Sri Lanka
Hemas Investor Relations: